Publications: Supplementary information

Percutaneous direct current stimulation – a new electroceutical solution for severe neurological pain and soft tissue injuries

Authors: Albrecht Molsberger1* Colin D. McCaig2

1 Department of Orthopedics, Ruhr-University Bochum, Germany

2 Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, Scotland.

Submitted to: Medical Devices: Evidence and Research

Supplementary videos

Video 1: Cluster headache and sequence of the treatment.

50 year old patient, suffering from chronic cluster headache. The first part of the interview was held after three percutaneous direct current stimulations, which were all delivered in the span of one week. The second part of the interview took place 10 weeks after the fourth treatment. Before treatment (baseline): 5-8 attacks per day, 2-8 triptan injections / day. 960 mg verapamil /day.  The cluster headache was episodic for 6 years and had become chronic for 1,5 years before the treatment. This patient received 8 treatments in 2015, 4 treatments in 2016 and 2017 respectively. He has been in full remission for 13 months.

 

 

Video 2: Muscle tears of the thigh.

The video shows the testimonial of a 32 year old professional ice hockey player with the condition after four muscle tears of the thigh, all within 4 months. Before treatment he suffered from continuous muscle pain since 4 months in resting and during sports, resulting in significant limitations when playing. The past conservative treatment in a clinic, specialized in sports medicine, was not successful, so percutaneous direct current treatment was recommended. The first part of the interview shows the patient after the second treatment. The second part of the interview is taken 6 weeks later. The patient had been able to perform in more than 20 ice hockey games completely free of limitations.